ECARX Holdings (ECXWW) Research & Development (2021 - 2026)

ECARX Holdings has reported Research & Development for 6 years, with the latest figure at -$23.5 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 31.88% year-over-year to -$23.5 million; the trailing twelve-month figure through Mar 2026 stood at -$112.3 million (up 34.67% YoY), and the FY2025 full-year result was $123.3 million, down 29.47% from the prior year.
• Research & Development for Q1 2026 stood at -$23.5 million, up from -$29.1 million in the prior quarter.
• The five-year high for Research & Development was -$23.5 million in Q1 2026, with the low at -$67.3 million in Q4 2022.
• Historically, Research & Development has averaged -$40.2 million across 5 years, with a median of -$37.3 million in 2024.
• Annual changes were most pronounced in 2023 — Research & Development sank 60.76% — and 2025, when it soared 45.82%.
• ECARX Holdings' Research & Development stood at -$67.3 million in 2022, then increased by 0.89% to -$66.7 million in 2023, then gained by 28.34% to -$47.8 million in 2024, then surged by 39.12% to -$29.1 million in 2025, then gained by 19.24% to -$23.5 million in 2026.
• The last three Research & Development figures came in at -$23.5 million (Q1 2026), -$29.1 million (Q4 2025), and -$25.9 million (Q3 2025), per Business Quant data.